Control group:Wenshen-Huatan-Quyu placebo plus valsartan

2 trials

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Conditions

Chironic kidney disease

Early Phase 1

Wenshen-Huatan-Quyu particle combined with valsartan for benign hypertensive nephrosclerosis: a randomized controlled trial

Active, not recruitingITMCTR1900002603

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineChironic kidney disease

Start: 2019-10-01Updated: 2023-02-20

Wenshen-Huatan-Quyu particle combined with valsartan for benign hypertensive nephrosclerosis: a randomized controlled trial

Active, not recruitingChiCTR1900026018

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese MedicineChironic kidney disease

Start: 2019-10-01Updated: 2019-09-30